GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFY) » Definitions » EV-to-Revenue

McKesson Europe AG (McKesson Europe AG) EV-to-Revenue : 0.41 (As of May. 15, 2024)


View and export this data going back to 2008. Start your Free Trial

What is McKesson Europe AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, McKesson Europe AG's enterprise value is $4,166 Mil. McKesson Europe AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $10,195 Mil. Therefore, McKesson Europe AG's EV-to-Revenue for today is 0.41.

The historical rank and industry rank for McKesson Europe AG's EV-to-Revenue or its related term are showing as below:

CAKFY's EV-to-Revenue is not ranked *
in the Medical Distribution industry.
Industry Median: 0.6
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), McKesson Europe AG's stock price is $4.10. McKesson Europe AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $10.03. Therefore, McKesson Europe AG's PS Ratio for today is 0.41.


McKesson Europe AG EV-to-Revenue Historical Data

The historical data trend for McKesson Europe AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG EV-to-Revenue Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.28 0.27 0.67 0.52

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.28 0.27 0.67 0.52

Competitive Comparison of McKesson Europe AG's EV-to-Revenue

For the Medical Distribution subindustry, McKesson Europe AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's EV-to-Revenue falls into.



McKesson Europe AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

McKesson Europe AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4166.010/10195.044
=0.41

McKesson Europe AG's current Enterprise Value is $4,166 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. McKesson Europe AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $10,195 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (OTCPK:CAKFY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

McKesson Europe AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.10/10.033
=0.41

McKesson Europe AG's share price for today is $4.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Mar. 2022 was $10.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (McKesson Europe AG) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines